Scienture Holdings, Inc.
جودة البيانات: 100%
SCNX
Nasdaq
Manufacturing
Chemicals
KWD 0.33
▼
KWD 0.01
(-2.35%)
القيمة السوقية: 14.21 M
السعر
KWD 0.35
القيمة السوقية
14.21 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue declined -54.29% annually over 5 years
Earnings declined -557.90% over the past year
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -13.39 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 270.16%
Capital efficient — spends only 2.78% of revenue on capex
النمو
Revenue Growth (5Y)
-54.29%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)215.87%
Earnings (1Y)-557.90%
FCF Growth (3Y)N/A
الجودة
Return on Equity
-51.72%
أعلى من متوسط القطاع (-53.34%)
ROIC-34.67%
Net Margin-9618.03%
Op. Margin-9867.92%
الأمان
Debt / Equity
0.02
أقل من متوسط القطاع (0.31)
Current Ratio0.19
Interest Coverage-10.43
التقييم
PE (TTM)
-0.34
أعلى من متوسط القطاع (-1.47)
P/B Ratio0.17
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -0.3 | -1.5 |
| P/B | 0.2 | 1.6 |
| ROE % | -51.7 | -53.3 |
| Net Margin % | -9618.0 | -41.5 |
| Rev Growth 5Y % | -54.3 | 1.8 |
| D/E | 0.0 | 0.3 |
السعر المستهدف للمحللين
محلل 1
Strong Buy
الحالي
KWD 0.33
المستهدف
KWD 1.50
KWD 1.50
KWD 1.50
KWD 1.50
التوقعات
مكرر الربحية المستقبلي
-1.59
ربحية السهم المستقبلية
-KWD 0.21
الإيرادات المقدّرة
17.22 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.21
-KWD 0.21 – -KWD 0.21
|
17.22 M | 1 |
| FY2026 |
-KWD 0.72
-KWD 0.72 – -KWD 0.72
|
5.07 M | 1 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.23
-KWD 0.23 – -KWD 0.23
|
0.0 | 1 |
| 2026 Q1 |
-KWD 0.22
-KWD 0.22 – -KWD 0.22
|
0.0 | 1 |
مفاجآت الأرباح
آخر 1 ربع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.28 | -KWD 0.13 | +54.7% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 215.87% | Revenue Growth (3Y) | -77.16% |
| Earnings Growth (1Y) | -557.90% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -54.29% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 431,609.0 | Net Income (TTM) | -41.51 M |
| ROE | -51.72% | ROA | -39.70% |
| Gross Margin | 76.80% | Operating Margin | -9867.92% |
| Net Margin | -9618.03% | Free Cash Flow (TTM) | -13.39 M |
| ROIC | -34.67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 0.19 |
| Interest Coverage | -10.43 | Asset Turnover | 0.00 |
| Working Capital | -5.93 M | Tangible Book Value | -15.10 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.34 | Forward P/E | N/A |
| P/B Ratio | 0.17 | P/S Ratio | 32.92 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -94.25% | ||
| Market Cap | 14.21 M | Enterprise Value | 16.21 M |
| Per Share | |||
| EPS (Diluted TTM) | -2.70 | Revenue / Share | 0.01 |
| FCF / Share | -0.33 | OCF / Share | -0.33 |
| EPS CAGR (1Y) | -208.87% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 2.78% | FCF Conversion | 32.26% |
| SBC-Adj. FCF | -15.21 M | Growth Momentum | 270.16 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 431,609.0 | 136,643.0 | 8.27 M | 11.45 M | 17.12 M |
| Net Income | -41.51 M | 9.07 M | -17.84 M | -3.47 M | -2.54 M |
| EPS (Diluted) | -2.70 | 2.48 | -7.49 | -0.41 | — |
| Gross Profit | 331,482.0 | 6,005.0 | 2.60 M | 5.45 M | 5.71 M |
| Operating Income | -42.59 M | -14.70 M | -7.26 M | -4.42 M | -2.51 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 1.96 M | 2.24 M | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 491,781.0 | — | — | — | — |
| Interest Expense | 4.08 M | 1.34 M | 1.20 M | 336,206.0 | 29,389.0 |
| Income Tax | -1.99 M | -534,396.0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2023 | FY2024 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 84.18 M | 12.53 M | 104.85 M | 3.71 M | 9.79 M |
| Total Liabilities | 14.06 M | 11.99 M | 25.78 M | 3.37 M | 1.11 M |
| Shareholders' Equity | 70.12 M | 542,353.0 | 79.07 M | 763,136.0 | 8.68 M |
| Total Debt | 2.90 M | — | 2.90 M | — | — |
| Cash & Equivalents | 6.66 M | 151,908.0 | — | 1.13 M | 5.92 M |
| Current Assets | 7.92 M | 2.75 M | 6.31 M | 2.09 M | 9.22 M |
| Current Liabilities | 2.74 M | 11.56 M | 7.91 M | 2.15 M | 842,238.0 |
{"event":"ticker_viewed","properties":{"ticker":"SCNX","listing_kind":"stock","pathname":"/stocks/scnx","exchange":"Nasdaq","country":"US"}}